ABOUT THE SPEAKER
Gregory Petsko - Bioengineer
Gregory Petsko is a biochemist who studies the proteins of the body and their biochemical function. Working with Dagmar Ringe, he's doing pioneering work in the way we look at proteins and what they do.

Why you should listen

Gregory Petsko's own biography, on his Brandeis faculty homepage, might seem intimidatingly abstruse to the non-biochemist -- he studies "the structural basis for efficient enzymic catalysis of proton and hydride transfer; the role of the metal ions in bridged bimetalloenzyme active sites; direct visualization of proteins in action by time-resolved protein crystallography; the evolution of new enzyme activities from old ones; and the biology of the quiescent state in eukaryotic cells."

But for someone so deeply in touch with the minutest parts of our bodies, Petsko is also a wide-ranging mind, concerned about larger health policy issues. The effect of mass population shifts -- such as our current trend toward a senior-citizen society -- maps onto his world of tiny proteins to create a compeling new worldview.

More profile about the speaker
Gregory Petsko | Speaker | TED.com
TED2008

Gregory Petsko: The coming neurological epidemic

Gregory Petsko om den kommende neurologiske epidemi

Filmed:
994,855 views

Biokemiker Gregory Petsko fremfører et overbevisende argument at, i løbet af de næste 50 år, vil vi se en epidemi af neurologiske lidelser, som Alzheimers, i takt med at verden bliver ældre. Hans løsning: mere forskning i hjernen og dens funktioner.
- Bioengineer
Gregory Petsko is a biochemist who studies the proteins of the body and their biochemical function. Working with Dagmar Ringe, he's doing pioneering work in the way we look at proteins and what they do. Full bio

Double-click the English transcript below to play the video.

00:12
UnlessMedmindre we do something to preventforhindre it,
0
0
2000
Medmindre vi gør noget for at forhindre det,
00:14
over the nextNæste 40 yearsflere år we’rere facingover an epidemicepidemi
1
2000
3000
vil vi i løbet af de næste 40 år stå overfor en epidemi
00:17
of neurologicneurologiske diseasessygdomme on a globalglobal scalevægt.
2
5000
3000
af neurologiske sygdomme på global skala.
00:20
A cheerymuntre thought.
3
8000
4000
En munter tanke.
00:24
On this mapkort, everyhver countryLand that’s coloredfarvet blueblå
4
12000
3000
På dette kort, har hvert land der er farvet blåt
00:27
has more than 20 percentprocent of its populationbefolkning over the agealder of 65.
5
15000
4000
en befolkning hvor mere end 20 procent er over 65 år gammel.
00:31
This is the worldverden we livelevende in.
6
19000
2000
Dette er den verden vi lever i.
00:33
And this is the worldverden your childrenbørn will livelevende in.
7
21000
3000
Og dette er den verden jeres børn vil leve i.
00:37
For 12,000 yearsflere år, the distributionfordeling of agesaldre in the humanhuman populationbefolkning
8
25000
4000
I 12.000 år, har inddelingen af alderen i den menneskelige befolkning
00:41
has lookedkigget like a pyramidpyramide, with the oldestældste on toptop.
9
29000
3000
set ud som en pyramide, med de ældste på toppen.
00:44
It’s alreadyallerede flatteningudfladning out.
10
32000
2000
Det begynder allerede at flade ud.
00:46
By 2050, it’s going to be a columnkolonne and will startStart to invertinverter.
11
34000
4000
I 2050, vil det være en kolonne og vil begynde at vende om.
00:50
This is why it’s happeningsker.
12
38000
3000
Dette er grunden til at det sker.
00:53
The averagegennemsnit lifespanlevetid’s more than doubledfordoblet sincesiden 1840,
13
41000
3000
Den gennemsnitlige levealder er mere end fordoblet siden 1840,
00:56
and it’s increasingstigende currentlyi øjeblikket at the ratesats of about fivefem hourstimer everyhver day.
14
44000
5000
og det øges for nuværende med en hastighed af fem timer hver dag.
01:01
And this is why that’s not entirelyhelt a good thing:
15
49000
3000
Og her er hvorfor det ikke kun er en god ting:
01:04
because over the agealder of 65, your riskrisiko of getting AlzheimerAlzheimers’s
16
52000
4000
fordi over 65 års alderen, ens risiko for at få Alzheimers
01:08
or ParkinsonParkinsons’s diseasesygdom will increaseøge exponentiallyeksponentielt.
17
56000
4000
eller Parkinson vil stige eksponentielt.
01:12
By 2050, there’llll be about 32 millionmillion people in the UnitedUnited StatesStater
18
60000
4000
I 2050, vil der være cirka 32 millioner mennesker i USA
01:16
over the agealder of 80, and unlessmed mindre we do something about it,
19
64000
3000
over 80 år, og medmindre vi gør noget ved det,
01:19
halfhalvt of them will have AlzheimerAlzheimers’s diseasesygdom
20
67000
2000
vil halvdelen af dem have Alzheimers
01:21
and threetre millionmillion more will have ParkinsonParkinsons’s diseasesygdom.
21
69000
3000
og yderligere tre millioner vil have Parkinsons.
01:24
Right now, those and other neurologicneurologiske diseasessygdomme --
22
72000
3000
Lige nu, disse og andre neurologiske lidelser --
01:27
for whichhvilken we have no curehelbrede or preventionforebyggelse --
23
75000
3000
som der ikke er nogen kur eller forebyggelse imod --
01:30
costkoste about a thirdtredje of a trillionbillioner dollarsdollars a yearår.
24
78000
2000
koster omkring en tredjedel af en billion dollars om året.
01:32
It will be well over a trillionbillioner dollarsdollars by 2050.
25
80000
4000
Det vil være et godt stykke over en billion dollars i 2050.
01:36
AlzheimerAlzheimers’s diseasesygdom startsstarter when a proteinprotein
26
84000
2000
Alzheimers begynder når proteiner
01:38
that should be foldedfoldet up properlykorrekt
27
86000
2000
der skulle foldes korrekt
01:40
misfoldsmisfolds into a kindvenlig of dementeddemente origamiorigami.
28
88000
4000
misfoldes til en slags dement origami.
01:44
So one approachnærme sig we’rere takingtager is to try to designdesign drugsstoffer
29
92000
3000
Så en tilgang som vi tager er at prøve at udvikle lægemidler
01:47
that functionfungere like molecularmolekylær ScotchScotch tapebånd,
30
95000
3000
der virker som en molekylær Scotch tape,
01:50
to holdholde the proteinprotein into its properkorrekt shapeform.
31
98000
3000
til at holde proteiner i deres rigtige form.
01:53
That would keep it from formingdannelse the tanglessammenfiltring
32
101000
2000
Det ville holde dem fra at forme det virvar
01:55
that seemsynes to killdræbe largestor sectionssektioner of the brainhjerne when they do.
33
103000
4000
der virker til at dræbe store dele af hjernen når de gør det.
01:59
InterestinglyInteressant enoughnok, other neurologicneurologiske diseasessygdomme
34
107000
2000
Interessant nok, andre neurologiske lidelser
02:01
whichhvilken affectpåvirke very differentforskellige partsdele of the brainhjerne
35
109000
3000
der påvirker meget andre dele af hjernen
02:04
alsoogså showat vise tanglessammenfiltring of misfoldedfejlfoldede proteinprotein,
36
112000
3000
viser også et virvar af misfoldede proteiner,
02:07
whichhvilken suggestsforeslår that the approachnærme sig mightmagt be a generalgenerel one,
37
115000
3000
hvilket foreslår at den tilgang måske er en general en,
02:10
and mightmagt be used to curehelbrede manymange neurologicneurologiske diseasessygdomme,
38
118000
2000
og måske kan bruges til at kurere mange neurologiske lidelser,
02:12
not just AlzheimerAlzheimers’s diseasesygdom.
39
120000
2000
ikke kun Alzheimers.
02:14
There’s alsoogså a fascinatingspændende connectionforbindelse to cancerKræft here,
40
122000
3000
Der er også en fascinerende forbindelse med kræft her,
02:17
because people with neurologicneurologiske diseasessygdomme
41
125000
2000
fordi mennesker med neurologiske lidelser
02:19
have a very lowlav incidenceincidens of mostmest cancerscancere.
42
127000
3000
har meget lave forekomster af de fleste kræftformer.
02:22
And this is a connectionforbindelse that mostmest people arenaren’t pursuingforfølge right now,
43
130000
3000
Og dette er en forbindelse som de fleste mennesker ikke forfølger lige nu,
02:25
but whichhvilken we’rere fascinatedfascineret by.
44
133000
3000
men som vi er fascineret af.
02:28
MostDe fleste of the importantvigtig and all of the creativekreativ work in this areaareal
45
136000
3000
Det meste af vigtige og al det kreative arbejde i dette område
02:31
is beingvære fundedfinansierede by privateprivat philanthropiesphilanthropies.
46
139000
3000
bliver finansieret af private filantroper.
02:34
And there’s tremendousenorm scopeanvendelsesområde for additionalyderligere privateprivat help here,
47
142000
3000
Og der er en forrygende rækkevide til yderligere privat hjælp her,
02:37
because the governmentregering has droppeddroppet the ballbold on much of this, I’m afraidbange.
48
145000
3000
fordi det offentlige er kommet helt bagud af dansen i meget af dette, er jeg bange for.
02:40
In the meantimemellemtiden, while we’rere waitingventer for all these things to happenske,
49
148000
4000
I mellemtiden, mens vi venter på at alle disse ting sker,
02:44
here’s what you can do for yourselfdig selv.
50
152000
2000
kan man gøre dette for sig selv.
02:46
If you want to lowernederste your riskrisiko of ParkinsonParkinsons’s diseasesygdom,
51
154000
2000
Hvis man vil sænke ens risiko for Parkinson,
02:48
caffeinekoffein is protectivebeskyttende to some extentgrad; nobodyingen knowskender why.
52
156000
5000
er koffein meget beskyttende til en vis grad; ingen ved hvorfor.
02:53
HeadHoved injuriesskader are baddårlig for you. They leadat føre to ParkinsonParkinsons’s diseasesygdom.
53
161000
3000
Skader på hovedet er dårlige for en. De leder til Parkinson.
02:56
And the AvianAviær FluInfluenza is alsoogså not a good ideaide.
54
164000
4000
Og fugleinfluenza er heller ikke nogen god ide.
03:01
As farlangt as protectingbeskyttelse yourselfdig selv againstmod AlzheimerAlzheimers’s diseasesygdom,
55
169000
3000
Hvad angår at beskytte sig selv mod Alzheimers,
03:04
well, it turnsdrejninger out that fishfisk oilolie has the effecteffekt
56
172000
3000
jamen, det viser sig at fiskeolie har den effekt
03:07
of reducingreduktion your riskrisiko for AlzheimerAlzheimers’s diseasesygdom.
57
175000
3000
at reducere ens risiko for Alzheimers.
03:10
You should alsoogså keep your bloodblod pressuretryk down,
58
178000
2000
Man bør også holde sit blodtryk nede,
03:12
because chronickronisk highhøj bloodblod pressuretryk
59
180000
2000
fordi kronisk højt blodtryk
03:14
is the biggeststørste singleenkelt riskrisiko factorfaktor for AlzheimerAlzheimers’s diseasesygdom.
60
182000
2000
er den største risiko for Alzheimers.
03:16
It’s alsoogså the biggeststørste riskrisiko factorfaktor for glaucomaglaukom,
61
184000
3000
Det er også den største risiko for stær,
03:19
whichhvilken is just AlzheimerAlzheimers’s diseasesygdom of the eyeøje.
62
187000
3000
hvilket bare er Alzheimers i øjet.
03:22
And of courseRute, when it comeskommer to cognitivekognitive effectseffekter,
63
190000
2000
Og selvfølgelig, når det kommer til kognitive effekter,
03:24
"use it or losetabe it" appliesgælder,
64
192000
2000
gælder "brug det eller mist det",
03:26
so you want to stayBliv mentallymentalt stimulatedstimuleret.
65
194000
2000
så man skal holde sig mentalt stimuleret.
03:28
But hey, you’rere listeninghører efter to me.
66
196000
2000
Men hey, I lytter til mig.
03:30
So you’veve got that covereddækket.
67
198000
2000
Så den er dækket ind.
03:32
And one finalendelige thing. WishØnske people like me luckheld, okay?
68
200000
4000
Og en sidste ting. Ønsk mennesker som mig held, okay?
03:36
Because the clockur is tickingtikkende for all of us.
69
204000
2000
Fordi tiden går for os alle sammen.
03:38
Thank you.
70
206000
3000
Tak

▲Back to top

ABOUT THE SPEAKER
Gregory Petsko - Bioengineer
Gregory Petsko is a biochemist who studies the proteins of the body and their biochemical function. Working with Dagmar Ringe, he's doing pioneering work in the way we look at proteins and what they do.

Why you should listen

Gregory Petsko's own biography, on his Brandeis faculty homepage, might seem intimidatingly abstruse to the non-biochemist -- he studies "the structural basis for efficient enzymic catalysis of proton and hydride transfer; the role of the metal ions in bridged bimetalloenzyme active sites; direct visualization of proteins in action by time-resolved protein crystallography; the evolution of new enzyme activities from old ones; and the biology of the quiescent state in eukaryotic cells."

But for someone so deeply in touch with the minutest parts of our bodies, Petsko is also a wide-ranging mind, concerned about larger health policy issues. The effect of mass population shifts -- such as our current trend toward a senior-citizen society -- maps onto his world of tiny proteins to create a compeling new worldview.

More profile about the speaker
Gregory Petsko | Speaker | TED.com